The management team is slated to deliver a company overview at Baird’s 2026 Global Healthcare Conference on September 15 at 10:50 a.m. Eastern time. Interested parties can access a live audio webcast of the presentation through the company’s investor relations portal, with an on-demand replay scheduled immediately following the live broadcast.
Castle Biosciences Sets September Investor Conference Schedule
Executives from Friendswood-based diagnostics firm Castle Biosciences will outline their growth strategy and portfolio of clinical tests at two upcoming investor forums this September. The company aims to detail its diagnostic approach for dermatologic and gastroenterological conditions before institutional audiences at the Baird and Lake Street capital market events.
Prior to the Baird session, the company will participate in the 10th annual Lake Street Best Ideas Growth (BIG10) Conference on September 10. During this event, Castle Biosciences representatives will hold one-on-one meetings with investors. Participation in these private sessions is managed exclusively through Lake Street Capital Markets.
Comments (0)
No comments yet. Be the first!